| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 09/18/2007 | US7271265 Cyanine compounds and their application as quenching compounds |
| 09/18/2007 | US7271264 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 09/18/2007 | US7271177 Solubility, dissolution rate and bioavailability; X-ray diffraction peak pattern comprising broad halo at 2 theta of about 17 degrees |
| 09/18/2007 | US7271165 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, 25-O-deacetyl-25-(2'',3''-dihydroxypropylcarbonoxy)-5'-[4-isobutyl-1-piperazinyl]benzoxazinorifamycin |
| 09/18/2007 | US7270857 Liquid crystal composition and liquid crystal element |
| 09/18/2007 | CA2259420C Erythromycins and process for their preparation |
| 09/13/2007 | WO2007103719A2 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 09/13/2007 | WO2007103347A1 Meridamycin analogues for the treatment of neurodegenerative disorders |
| 09/13/2007 | WO2007102580A1 Polycyclic cinnamide derivative |
| 09/13/2007 | WO2007075307A3 Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate |
| 09/13/2007 | WO2007056215A9 N-aryl-thienopyrimidin-4-amines and the use thereof |
| 09/13/2007 | US20070213360 Tetrahydropyridothiophenes for Use in the Treatment of Cancer |
| 09/13/2007 | US20070213337 Modulators of serotonin receptors |
| 09/13/2007 | US20070213320 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | CA2643796A1 Polycyclic cinnamide derivatives |
| 09/13/2007 | CA2643350A1 Meridamycin analogues for the treatment of neurodegenerative disorders |
| 09/12/2007 | EP1832592A2 15-C Isomers of rapamycin and of 42-EPI rapamycin, preparation and use thereof |
| 09/12/2007 | EP1831231A1 Nicotinic acetylcholine receptor ligands |
| 09/12/2007 | EP1831230A1 Process for obtaining levofloxacin free from salts |
| 09/12/2007 | EP1831226A2 CHIRAL FUSED 1,2 IMIDAZO 4,5-c RING COMPOUNDS |
| 09/12/2007 | EP1831222A1 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity |
| 09/12/2007 | CN101035794A Polymeric/oligomeric methacrylate functionalized amide acetals in coatings |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268144 Regiospecific synthesis of rapamycin 42-ester derivatives |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | US7268131 Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma |
| 09/07/2007 | WO2007067698A3 Isolation of ansamitocins |
| 09/06/2007 | US20070208069 Pharmaceutical formulations of an anhydrous crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 09/06/2007 | US20070208055 Alternative synthesis of renin inhibitors and intermediates thereof |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208040 e.g. 3-ethyl-5-methyl-1,3-dihydrothiopheno[2,3-d]pyrimidine-2,4-dione; neurodegenerative disorders, antiischemic agent, antidepressant, attention deficit disorder, hepatic fibrosis, cirrhosis of the liver, and drug addiction |
| 09/06/2007 | US20070208003 Compounds and methods for treating dyslipidemia |
| 09/05/2007 | EP1829882A2 Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same |
| 09/05/2007 | EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same |
| 09/05/2007 | EP1829880A2 Derivatives of camptothecin for use in treating cancer |
| 09/05/2007 | EP1828205A1 Method of purifying tacrolimus |
| 09/05/2007 | EP1828204A1 Method of purifying macrolides |
| 09/05/2007 | EP1828203A2 Rapamycin derivatives and the uses thereof in the treatment of neurological disorders |
| 09/05/2007 | EP1828202A2 Rapamcyin analogues and the uses thereof in the treatment of neurologial proliferative and inflammatory disorders |
| 09/05/2007 | EP1828201A2 Macrocyclic quinazoline derivatives and their use as mtki |
| 09/05/2007 | EP1828188A1 Bridged ring nk1 antagonists |
| 09/05/2007 | EP1828181A2 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 09/05/2007 | EP1828167A2 Acrylamide derivatives as antibiotic agents |
| 09/05/2007 | EP1569638B1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 09/05/2007 | EP1492796B1 Substituted amino isoxazoline derivatives and their use as anti-depressants. |
| 09/05/2007 | EP1463733B1 Mitotic kinesin inhibitors |
| 09/05/2007 | EP1336611B1 Dehalogeno compounds |
| 09/05/2007 | CN101031654A Process for isolation of crystalline tacrolimus |
| 09/05/2007 | CN101031653A Process for isolation of macrolide compounds |
| 09/05/2007 | CN101031573A Heteroatoms-containing tricyclic compounds |
| 09/05/2007 | CN101031572A (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions |
| 09/05/2007 | CN101031571A Hydroxy amide acetals and their use in coatings |
| 09/05/2007 | CN101029051A (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 09/05/2007 | CN101028538A Medical devices containing rapamycin analogs |
| 09/05/2007 | CN100335054C Quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for treatment of helicobacter pylori infections and associated gastroduodenal |
| 09/04/2007 | US7265228 N-(alpha-methylolbenzyl)1-(aminoethyl)- or 1-(aminocarbonyl)-2-aryl(especially phenyl or benzodioxanyl)-2-hydroxyethylamine intermediates for enantiomeric synthesis of amino ceramide-like compounds |
| 09/04/2007 | US7265128 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/04/2007 | US7265120 Pyrazine derivatives and pharmaceutical use thereof |
| 09/04/2007 | US7265108 For example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 09/04/2007 | US7265107 For therapy and prophylaxis of microbial infections |
| 09/04/2007 | US7265103 For therapy of depression, anxiety and body weight disorders |
| 08/30/2007 | WO2007096351A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders |
| 08/30/2007 | WO2006113837A3 Inhibitors of akt activity |
| 08/30/2007 | US20070203223 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease |
| 08/30/2007 | US20070203127 Antibacterial Agents |
| 08/30/2007 | CA2638095A1 New compounds |
| 08/30/2007 | CA2618741A1 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 08/29/2007 | EP1826213A1 Rapamycin analogs containing an antioxidant moiety |
| 08/29/2007 | EP1826212A1 Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same |
| 08/29/2007 | EP1826211A1 Isomers and 42-Epimers of rapamycin alkyl ether analogs, methods of making and using the same |
| 08/29/2007 | EP1824856A1 2,4 (4,6) pyrimidine derivatives |
| 08/29/2007 | EP1824828A2 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 08/29/2007 | EP1824821A2 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 08/29/2007 | EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 08/29/2007 | CN101027395A Biosynthetic gene cluster for the production of a complex polyketide |
| 08/29/2007 | CN101027309A Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer |
| 08/29/2007 | CN101027301A Fused ring azadecalin glucocorticoid receptor modulators |
| 08/29/2007 | CN101027297A Macrocyclic beta-secretase inhibitors |
| 08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 08/29/2007 | CN101027285A Process for preparing bicyclic pyrazolyl compounds |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/28/2007 | US7262300 New crystalline monohydrates and crystalline anhydrates of gaboxadol; suitable for oral dosage administration |
| 08/28/2007 | US7262294 Wear resistance and high colourability characteristics; for use in paints, lacquers, paints or lacquers based on hybrid polysiloxanes and/or silica gel, plastics |
| 08/28/2007 | US7262212 Antitubercular agent; antibiotic against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria; e.g. (R)-2-methyl-6-nitro-2-(4-(4-(4-trifluoromethoxyphenoxy)piperidin-1-yl)phenoxymethyl)-2,3-dihydroimidazo(2,1-b)oxazole |
| 08/28/2007 | US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor |
| 08/28/2007 | CA2579758A1 Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same |
| 08/28/2007 | CA2579735A1 Isomers of rapamycin and 42-epi-rapamycin, methods of making and using the same |
| 08/28/2007 | CA2579734A1 Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same |
| 08/28/2007 | CA2579731A1 Rapamycin analogs containing an antioxidant moiety |
| 08/28/2007 | CA2579699A1 Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same |
| 08/28/2007 | CA2160243C 36-derivatives of rifamycins and their use as antimicrobial agents |
| 08/23/2007 | WO2007095423A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 08/23/2007 | WO2007093963A1 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 08/23/2007 | WO2007093870A2 A process for the preparation of risperidone |
| 08/23/2007 | WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 08/23/2007 | WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | WO2007075884A3 Androgen receptor modulator compounds and methods |
| 08/23/2007 | WO2007015866A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders |
| 08/23/2007 | US20070197789 Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein |